Educational Alliance to Optimize CV risk management
CV Risk Master Classes: Applying new insights to clinical practice

 
The lectures are recorded during the CardioVascular Risk Master Class, Asian chapter, held on May 10-11, 2013 in Kuala Lumpur, Malaysia. The presentations are intended for educational support of participants to the meeting. To view and open the presentations an additional log-on with a passcode is required. This passcode is provided to meeting participants only.

 

Click here to view the presentations

 

The challenge for CV Risk management in Asia:
What are the key opportunities?

Dato' Dr. Khoo Kah Lin, Kuala Lumpur, Malaysia

 

 

Call for action to prevent CV disease in Asia:
New strategies for early intervention

Prof John Deanfield, MD, UCL, London, United Kingdom

 

 

Macrovascular disease in diabetes;
Opportunities for lipid management

Prof. Karen Lam, MD, The University of Hong Kong, Hong Kong

 

 

Latest insights from clinical trials:

The unassailable case for LDL-c lowering & statin therapy

Kees Hovingh, MD, Academic Medical Centre, Amsterdam,The Netherlands

 

 

Blood pressure lowering and the prevention of CV disease and stroke

Prof. Peter Sever, MD, Imperial College London, United Kingdom

 

 

Novel therapies for the prevention of atherosclerotic vascular disease

John Kastelein, MD, Academic Medical Centre, Amsterdam, The Netherlands

 

 

The kidney & statin therapy: Friend or Foe?

Kees Hovingh, MD,  Academic Medical Centre, Amsterdam,The Netherlands

 

 

Update on new CV Risk guidelines: an international perspective

Prof. John Deanfield, MD,  UCL, London, United Kingdom